285 related articles for article (PubMed ID: 26951843)
1. Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
Evans LC; Ivy JR; Wyrwoll C; McNairn JA; Menzies RI; Christensen TH; Al-Dujaili EA; Kenyon CJ; Mullins JJ; Seckl JR; Holmes MC; Bailey MA
Circulation; 2016 Apr; 133(14):1360-70. PubMed ID: 26951843
[TBL] [Abstract][Full Text] [Related]
2. 11β-Hydroxysteroid Dehydrogenase-2 and Salt-Sensitive Hypertension.
Luft FC
Circulation; 2016 Apr; 133(14):1335-7. PubMed ID: 26951844
[No Abstract] [Full Text] [Related]
3. Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure.
Bailey MA; Craigie E; Livingstone DEW; Kotelevtsev YV; Al-Dujaili EAS; Kenyon CJ; Mullins JJ
Hypertension; 2011 Mar; 57(3):515-520. PubMed ID: 21282561
[TBL] [Abstract][Full Text] [Related]
4. Renal Dysfunction Induced by Kidney-Specific Gene Deletion of
Ueda K; Nishimoto M; Hirohama D; Ayuzawa N; Kawarazaki W; Watanabe A; Shimosawa T; Loffing J; Zhang MZ; Marumo T; Fujita T
Hypertension; 2017 Jul; 70(1):111-118. PubMed ID: 28559392
[TBL] [Abstract][Full Text] [Related]
5. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
[TBL] [Abstract][Full Text] [Related]
6. Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice.
Craigie E; Evans LC; Mullins JJ; Bailey MA
Hypertension; 2012 Sep; 60(3):684-90. PubMed ID: 22777941
[TBL] [Abstract][Full Text] [Related]
7. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P
Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
[TBL] [Abstract][Full Text] [Related]
8. In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence.
Manning JR; Bailey MA; Soares DC; Dunbar DR; Mullins JJ
Physiol Genomics; 2010 Aug; 42(3):319-30. PubMed ID: 20571110
[TBL] [Abstract][Full Text] [Related]
9. Abnormal neonatal sodium handling in skin precedes hypertension in the SAME rat.
Mullins L; Ivy J; Ward M; Tenstad O; Wiig H; Kitada K; Manning J; Rakova N; Muller D; Mullins J
Pflugers Arch; 2021 Jun; 473(6):897-910. PubMed ID: 34028587
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone-sensitive HSD2 neurons in mice.
Gasparini S; Resch JM; Narayan SV; Peltekian L; Iverson GN; Karthik S; Geerling JC
Brain Struct Funct; 2019 Jan; 224(1):387-417. PubMed ID: 30343334
[TBL] [Abstract][Full Text] [Related]
11. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
12. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
Vitellius G; Delemer B; Caron P; Chabre O; Bouligand J; Pussard E; Trabado S; Lombes M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5205-5216. PubMed ID: 31225872
[TBL] [Abstract][Full Text] [Related]
13. A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice.
Evans LC; Livingstone DE; Kenyon CJ; Jansen MA; Dear JW; Mullins JJ; Bailey MA
Am J Physiol Renal Physiol; 2012 Aug; 303(4):F494-502. PubMed ID: 22622456
[TBL] [Abstract][Full Text] [Related]
14. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess.
Bailey MA; Paterson JM; Hadoke PW; Wrobel N; Bellamy CO; Brownstein DG; Seckl JR; Mullins JJ
J Am Soc Nephrol; 2008 Jan; 19(1):47-58. PubMed ID: 18032795
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
Frey FJ; Odermatt A; Frey BM
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
[TBL] [Abstract][Full Text] [Related]
16. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.
Ferrari P; Krozowski Z
Kidney Int; 2000 Apr; 57(4):1374-81. PubMed ID: 10760070
[TBL] [Abstract][Full Text] [Related]
17. Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.
Morineau G; Sulmont V; Salomon R; Fiquet-Kempf B; Jeunemaître X; Nicod J; Ferrari P
J Am Soc Nephrol; 2006 Nov; 17(11):3176-84. PubMed ID: 17035606
[TBL] [Abstract][Full Text] [Related]
18. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
19. Two Mineralocorticoid Receptor-Mediated Mechanisms of Pendrin Activation in Distal Nephrons.
Ayuzawa N; Nishimoto M; Ueda K; Hirohama D; Kawarazaki W; Shimosawa T; Marumo T; Fujita T
J Am Soc Nephrol; 2020 Apr; 31(4):748-764. PubMed ID: 32034107
[TBL] [Abstract][Full Text] [Related]
20. Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia.
Fan P; Lu YT; Yang KQ; Zhang D; Liu XY; Tian T; Luo F; Wang LP; Ma WJ; Liu YX; Zhang HM; Song L; Cai J; Lou Y; Zhou XL
Endocrine; 2020 Dec; 70(3):607-615. PubMed ID: 32816205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
